{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:38:31Z","timestamp":1784745511731,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bill Gates"},{"name":"Global Good Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Despite increased efforts and spending toward polio eradication, it has yet to be eliminated worldwide. We aimed to project economic costs of polio eradication compared to permanent control. We used historical Financial Resource Requirements from the Global Polio Eradication Initiative, as well as vaccination and population data from publicly available sources, to project costs for routine immunization, immunization campaigns, surveillance and laboratory resources, technical assistance, social mobilization, treatment, and overhead. We found that cumulative spending for a control strategy would exceed that for an eradication strategy in 2032 (range, 2027\u20132051). Eradication of polio would likely be cost-saving compared to permanent control.<\/jats:p>","DOI":"10.1093\/infdis\/jiz488","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T11:24:46Z","timestamp":1569497086000},"source":"Crossref","is-referenced-by-count":11,"title":["Projection of Costs of Polio Eradication Compared to Permanent Control"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-8923","authenticated-orcid":false,"given":"Marita","family":"Zimmermann","sequence":"first","affiliation":[{"name":"Global Development Research, Institute for Disease Modeling, Bellevue, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"Global Development Research, Institute for Disease Modeling, Bellevue, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hil","family":"Lyons","sequence":"additional","affiliation":[{"name":"Global Development Research, Institute for Disease Modeling, Bellevue, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"2019102210391004800_CIT0001","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"key":"2019102210391004800_CIT0002","first-page":"S7","article-title":"The estimated health and economic benefits of three decades of polio elimination efforts in India","volume":"53","author":"Nandi","year":"2016","journal-title":"Indian Pediatr"},{"key":"2019102210391004800_CIT0003","article-title":"Progress on eradicating polio has stalled","year":"2018","journal-title":"The Economist"},{"key":"2019102210391004800_CIT0004","author":"Population Division - United Nations"},{"key":"2019102210391004800_CIT0005"},{"key":"2019102210391004800_CIT0006","author":"Neumann","year":"2017"},{"key":"2019102210391004800_CIT0007","author":"GPEI"},{"key":"2019102210391004800_CIT0008","author":"World Health Organization"},{"key":"2019102210391004800_CIT0009","volume-title":"WHO\/UNICEF Estimates of National Immunization Coverage (WUENIC)","author":"World Health Organization","year":"2018"},{"key":"2019102210391004800_CIT0010","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"210","author":"Okayasu","year":"2014","journal-title":"J Infect Dis"},{"key":"2019102210391004800_CIT0011","volume-title":"WHO | Fractional dose IPV","author":"World Health Organization","year":"2019"},{"key":"2019102210391004800_CIT0012","author":"World Health Organization"},{"key":"2019102210391004800_CIT0013","doi-asserted-by":"crossref","first-page":"A99","DOI":"10.1016\/j.vaccine.2014.12.037","article-title":"Costs of vaccine programs across 94 low- and middle-income countries","volume":"33","author":"Portnoy","year":"2015","journal-title":"Vaccine"},{"key":"2019102210391004800_CIT0014","author":"UNICEF"},{"key":"2019102210391004800_CIT0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12879-015-1112-8","article-title":"An economic analysis of poliovirus risk management policy options for 2013\u20132052","volume":"15","author":"Duintjer Tebbens","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz488\/30260003\/jiz488.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz488\/30260003\/jiz488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T16:26:36Z","timestamp":1571761596000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiz488\/5576004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":15,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz488","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"article-number":"jiz488"}}